Looking for scientific evidence to support our day-to-day clinical decisions
FDA warns of drug compounding amid shortages of drugs containing semaglutide
Semaglutide (Wegovy; Novo Nordisk) for obesity in adolescents, along with 2 other approved products containing semaglutide, are currently on the FDA’s drug shortages list, prompting the agency to warn patients and providers about drug compounding.
Food Insecurity and the Dangers of Infant Formula Dilution
Low-dose atropine eye drops may reduce myopia progression in children
Results from the phase 3 CHAMP trial may support low-dose atropine as a pharmacological treatment option for myopia progression in children.
Demystifying Infant Formula
Five months into 2023, staffing remains a challenge for health care
Some staffing problems stabilize with financial incentives, and technology helps, but an AMGA report shows predictions for this year hold true.
Using telehealth to optimize patient care in pediatric type 1 diabetes mellitus
A recent study looked at how patients with type 1 diabetes used telehealth during the pandemic, and how it has influenced their preferred method of health care.
2 Clarke Drive Cranbury, NJ 08512